Sure Chill is a cooling technology that can allow products to stay cool using mains electricity or renewable solar power. Sure Chill uses a phase change material instead of batteries to store energy until it is needed. It has been used to power a vaccine refrigerator recognized by the World Health Organization that can operate on a mains supply of less than five hours a day. After it is charged, it can maintain a constant cooling below 10 degrees Celsius without any power for over 10 days. Sure Chill also has an intelligent monitoring system to keep temperatures stable if there are any hotspots in order to extract heat and protect the stock of vaccines.
PATH has collaborated with the University of Washington, Seattle Children's Craniofacial Center and Komfo Anokye Teaching Hospital in Kumasi, Ghana to develop the Neonatal Intuitive Feeding TechnologY (NIFTY) cup. The NIFTY cup is an inexpensive, easy to use, efficient prototype technology used to deliver breast milk or formula to infants that are unable to breastfeed. The cup is able to catch hand-expressed breast milk directly and feed the infant. NIFTY is intended to be used by caregivers, community health workers, and midwives using pictorial instructions as an aid for the already intuitive device. Currently, the developers are conducting an inventory of infant cup feeding options, determining product specifications, and creating a prototype.
A team from Jhpiego and JHU-CBID are developing the Automatically Deflating Air Postpartum Tamponade (ADAPT) to manage postpartum hemorrhage (PPH) in low-resource settings.
This device will be designed specifically for use in low-resource settings.
DIIME has developed a mechanical autologous transfusion device in conjunction with clinicians at the Komfo Anokye Teaching Hospital in Kumasi, Ghana called Hemafuse. The device is meant to replace traditional autologous blood transfusions done commonly in developing countries where there are shortages of donated blood. Traditionally, the patient's own blood is filtered through gauze and mixed with anti-coagulant, often leading to severe complications. Hemafuse is a handheld, reusabale device that is a safer alternative to transfusions, specifically to address ruptured ectopic pregnancies. During surgery, the tip of the device is inserted into the patient's abdomen and blood is removed through manual suction. A filter removes clots and particulates.
Alain Labrique and co-investigators from the Bloomberg School of Public Health are working on a mobile-based health project called mCare. The purpose of mCare is to increase the survival of high-risk neonates in rural South Asia through an integrated mobile phone-based data system. The system connects rural community health care workers with pregnant women in order to improve pregnancy and birth registration, target delivery of care to high risk mothers and neonates and enhance survival or preterm neonates in low-resource settings.
Innovations in International Health at MIT, has partnered with the Global Health Committee, and Global Health Center at Massachusetts General Hospital, to develop a solar-powered refrigerator called CoolComply to store medications to treat Mutli-Drug Resistant Tuberculosis (MDR-TB) and monitor patient adherence. CoolComply features a wireless technology to send data about the temperature of the medication and patient adherence levels to local providers through SMS. The current prototype contains a microcontroller board and cell phone module.
Researchers participating in MIT's Innovations in International Health program have created a solar surgical tool sterilizer that is being field tested in Nicaragua. A low-cost substitute to autoclaves, the Solarclave has a reflector that can focus sunlight onto the surgical instruments placed on a vessel. The vessel is a pressure cooker that can be purchased locally that is wrapped in fiberglass insulation and built into a bucket suspended upside down. The light rays can heat the vessel over 300 degrees F, well over the 250 degrees F minimum sterilization requirement, and can sterilize the contents within an hour even on cloudy days.
Firefly is a low-cost phototherapy device used to treat jaundice in newborns developed by Design that Matters, East Meets West Foundation, and the Vietnamese manufacturer MTTS. It is designed for use in rural hospitals. The device includes top and bottom fixed light phototherapy to ensure continuous and effective treatment to the newborn. It also has an enclosed housing and a removable bassinet that can easily fit on a tabletop. Firefly incorporates DtM's award-winning infant thermoregulation and continuous positive airway pressure technology. It is priced at $350 and is currently being tested in Vietnamese hospitals.
Global Solutions for Infectious Diseases from CA is developing a low-cost rapid diagnostic test that will accurately diagnose and report anemia, HIV, syphilis, and malaria. The hand-held instrument will read and record test results as well as report the results in real time through automated wireless reports to health authorities. This data will allow for disease tracking in order to make decisions based on resource availability. As of now, the organization is working on multi-testing ability of the instrument as well as the reading of barcodes for management of pharmaceutical products. This technology came to our attention through Saving Lives at Birth Challenge, 2011.
The Program for Appropriate Technology In Health is developing a solar-powered infant warmer to provide initial warmth before skin-to-skin care is provided to prevent infant death by hypothermia. The warmers lightweight photovoltaic modules developed by HighFlex Solar, Inc and phase-change material will be used to store and maintain heat. It will also include a temperature monitoring device. The warmer will be less than $200 and is currently in development. A two year grant will be used to design and test the warmer until introducing a final design. This technology came to our attention through the Saving Lives at Birth Challenge, 2011.